Stay updated on AFM24 + Atezolizumab in EGFR+ Cancers Clinical Trial
Sign up to get notified when there's something new on the AFM24 + Atezolizumab in EGFR+ Cancers Clinical Trial page.

Latest updates to the AFM24 + Atezolizumab in EGFR+ Cancers Clinical Trial page
- CheckyesterdayChange DetectedAdded a recruitment-status note indicating enrollment has ceased, and introduced new help/navigation sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study', along with a site revision tag 'Revision: v3.6.0'.SummaryDifference0.5%

- Check9 days agoChange DetectedThe page revision tag was updated from v3.5.4 to v3.5.5, signaling a new version of the content.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4, signaling a new version of the page content. This change represents a refresh of the page’s metadata and accompanying text for the study record.SummaryDifference0.0%

- Check44 days agoChange DetectedThe page’s revision label was updated to v3.5.3, replacing v3.5.2, indicating an update to the page’s revision history rather than to study content.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page shows an updated site revision label: Revision: v3.5.2, replacing the previous Revision: v3.5.0.SummaryDifference0.0%

- Check87 days agoChange DetectedRevision: v3.5.0 has been added and Revision: v3.4.3 has been removed.SummaryDifference0.0%

Stay in the know with updates to AFM24 + Atezolizumab in EGFR+ Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AFM24 + Atezolizumab in EGFR+ Cancers Clinical Trial page.